BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 6129826)

  • 1. [Synthesis of aryloxypropanolamines with chromone or coumarin structures. Study of beta-blocking activity].
    Gesquière JC; Dhaisne JM; Marcinal-Lefebvre A; Bar D; Vincent A; Dupuis B
    Ann Pharm Fr; 1982 Sep; 40(3):251-7. PubMed ID: 6129826
    [No Abstract]   [Full Text] [Related]  

  • 2. Synthesis and beta-adrenergic blocking activity of oxipropanolamines of 3,4-dihydro-3-oxo-2H(1,4)benzothiazine.
    Cecchetti V; Fravolini A; Fringuelli R; Schiaffella F; Mascellani G; Pagella PG; Rugarli PL
    Farmaco Sci; 1987 Jan; 42(1):61-75. PubMed ID: 2898382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Various syntheses of therapeutic interest in the coumarin and chromone series].
    Mesnard P
    Farmaco Sci; 1970 Jan; 25(1):57-83. PubMed ID: 5414141
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis of certain 3-[4-[2-hydroxy-3-(isopropylamino) propoxy]phenyl]propionate as beta-adrenergic blocking agents.
    Ahmed AN
    J Pharm Belg; 1987; 42(6):389-94. PubMed ID: 2895806
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and pharmacological activity of some 1-alkylamino-3-(2'-methoxy-4'-diethylcarbamoyl-phenoxy)propan-2-ols.
    Monforte P; Basile M; Previtera T; Larizza A; Marmo E; De Gennaro G; Montinaro C; Filippelli W; Montanaro CS; Marfella A; Larizza D
    Farmaco Sci; 1983 Mar; 28(3):173-86. PubMed ID: 6133779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Adrenergic beta 1 and beta 2 blocking activity of new aminopropanols derived from oximes and esters].
    Rosell G; Mauleón D; Granados R; Selva C
    Arch Farmacol Toxicol; 1984 Aug; 10(2):101-6. PubMed ID: 6151379
    [No Abstract]   [Full Text] [Related]  

  • 7. Synthesis and beta-adrenergic antagonist activity of novel (3-cyanodihydropyridyl)propanolamines.
    Vo D; Wolowyk MW; Knaus EE
    Drug Des Discov; 1991 Dec; 8(2):157-64. PubMed ID: 1686561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. beta-Adrenoceptor blocking activity of 3-alkylamino-1-(3-benzo[ b ]thienyloxy)-2-propanols and closely related bicyclic compounds.
    Conde S; Corral C; Lissavetzky J; Darias V; Galván O
    Arch Pharm (Weinheim); 1983 Jun; 316(6):537-44. PubMed ID: 6136264
    [No Abstract]   [Full Text] [Related]  

  • 9. In vivo antitumor, in vitro antibacterial activity and alkylating properties of phosphorohydrazine derivatives of coumarin and chromone.
    Nawrot-Modranka J; Nawrot E; Graczyk J
    Eur J Med Chem; 2006 Nov; 41(11):1301-9. PubMed ID: 16904795
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on new -adrenergic blocking agents. I. Syntheses and pharmacology of coumarin derivatives.
    Sato Y; Kobayashi Y; Nagasaki T; Oshima T; Kumakura S
    Chem Pharm Bull (Tokyo); 1972 May; 20(5):905-17. PubMed ID: 4403400
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis, spectroscopy and alkylating properties of Pd(II) complexes of phosphorohydrazones of coumarin and chromone with potential antibacterial activity.
    Nawrot-Modranka J; Nawrot E
    Acta Pol Pharm; 2007; 64(5):429-34. PubMed ID: 18540163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-(Isoxazolylethenyl)phenoxypropanolamines: a new class of beta-receptor antagonists with antihypertensive activity.
    Franke A; Frickel FF; Gries J; Lenke D; Schlecker R; Thieme PD
    J Med Chem; 1981 Dec; 24(12):1460-4. PubMed ID: 6118439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bis-arenoxypropanolamines as potential beta-adrenolytics: a reinvestigation.
    Da Re P; Valenti P; Fabbri G; Frigeni V; Reggiani A; Della Bella D
    Drugs Exp Clin Res; 1988; 14(11):687-92. PubMed ID: 2907738
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and beta-adrenoceptor blocking activity of thiophenic analogues of metoprolol.
    Conde S; Corral C; Lissavetzky ; Darias V; Martin D
    Farmaco Sci; 1986 Jan; 41(1):80-8. PubMed ID: 2869971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Syntheses of the optical isomers of befunolol.HCl and their beta-adrenergic blocking activities.
    Nakano J; Mimura M; Hayashida M; Fujii M; Kimura K; Nakanishi T
    Chem Pharm Bull (Tokyo); 1988 Apr; 36(4):1399-403. PubMed ID: 2901296
    [No Abstract]   [Full Text] [Related]  

  • 16. [On the synthesis of compounds with beta-adrenergic activity (author's transl)].
    Lehmann D; Eckardt R; Faust G; Fiedler W
    Pharmazie; 1980; 34(5-6):278-84. PubMed ID: 6106206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationship of some new beta-blocking agents with possible alpha-adrenoreceptor activity.
    Bergmann J; Takács K
    Arch Pharm (Weinheim); 1990 Jul; 323(7):387-91. PubMed ID: 1978654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Syntheses and beta-adrenergic binding affinities of (R)- and (S)-fluoronaphthyloxypropanolamines.
    Adejare A; Deal SA; Day MS
    Chirality; 1999; 11(2):144-8. PubMed ID: 9951404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The synthesis of beta receptor blocking substances].
    Bercher H; Ehlers D; Grisk A
    Pharmazie; 1976 Jun; 31(6):351-4. PubMed ID: 8792
    [No Abstract]   [Full Text] [Related]  

  • 20. Synthesis and beta-adrenergic antagonist activity of heterocyclic propanolamines.
    Vo D; Wolowyk MW; Knaus EE
    Drug Des Discov; 1993 Jun; 10(2):89-99. PubMed ID: 8104518
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.